Abatacept With Methotrexate- Phase IIB

PHASE2CompletedINTERVENTIONAL
Enrollment

524

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept (BMS-188667)

IV, 10 mg/Kg, monthly, for the duration of the trial

DRUG

Abatacept (BMS-188667)

Intravenous (IV) infusion, 2 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months

DRUG

Abatacept (BMS-188667)

Intravenous (IV) infusion, 10 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months

DRUG

Placebo

Intravenous (IV) infusion, 0 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months

Trial Locations (57)

Unknown

Local Institution, Birmingham

Local Institution, Huntsville

Local Institution, Long Beach

Local Institution, Highlands Ranch

Local Institution, Largo

Local Institution, Titusville

Local Institution, West Palm Beach

Local Institution, Rome

Local Institution, Chicago

Local Institution, Wichita

Local Institution, Cumberland

Local Institution, Springfield

Local Institution, Worcester

Local Institution, Duluth

Local Institution, Lincoln

Local Institution, Albuquerque

Local Institution, Los Alamos

Local Institution, Albany

Local Institution, Binghamton

Local Institution, The Bronx

Local Institution, Portland

Local Institution, Duncansville

Local Institution, Sellersville

Local Institution, Amarillo

Local Institution, Austin

Local Institution, Dallas

Local Institution, Buenos Aries

Local Institution, Quilmes

Local Institution, Adelaide

Local Institution, Malvern

Local Institution, Perth

Local Institution, Antwerp

Local Institution, Brussels

Local Institution, Ghent

Local Institution, Leuven

Local Institution, Mons

Local Institution, Edmonton

Local Institution, Ottawa

Local Institution, Toronto

Local Institution, Montreal

Local Institution, Sherbrooke

Local Institution, Ste-Foy

Local Institution, St. John's

Local Institution, Montpellier

Local Institution, Strasbourg

Local Institution, Paris

Local Institution, Berlin

Local Institution, Freiburg im Breisgau

Local Institution, Jena

Local Institution, Cork

Local Institution, Nijmegen

Local Institution, Muckleneuk

Local Institution, Cape Town

Local Institution, Cambridge

Local Institution, Manchester

Local Institution, Maidstone

Local Institution, Leeds

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY